Simon Hales analyst CITI

Currently out of the existing stock ratings of Simon Hales, 13 are a BUY (76.47%), 4 are a HOLD (23.53%).

Simon Hales

Work Performance Price Targets & Ratings Chart

Analyst Simon Hales, currently employed at CITI, carries an average stock price target met ratio of 57.5% that have a potential upside of 15.5% achieved within 322 days.

Simon Hales’s has documented 32 price targets and ratings displayed on 5 stocks. The coverage is on the Consumer Defensive sector.

Most recent stock forecast was given on CCEP, Coca-Cola European Partners PLC at 10-Jan-2024.

Wall Street Analyst Simon Hales

Analyst best performing recommendations are on CCEP (COCA-COLA EUROPEAN PARTNERS PLC).
The best stock recommendation documented was for CCEP (COCA-COLA EUROPEAN PARTNERS PLC) at 6/22/2020. The price target of $47.04 was fulfilled within 239 days with a profit of $12.65 (36.78%) receiving and performance score of 1.54.

Average potential price target upside

CCEP Coca-Cola European Partners PLC DEO Diageo PLC ADR PM Philip Morris International BTI British American Tobacco p.l.c. BUD Anheuser Busch Inbev NV ADR

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

85

$4.51 (5.60%)

82

22 days ago

15/18 (83.33%)

$11.34 (15.40%)

398

Buy

82

$1.51 (1.88%)

55

1 months 21 days ago

3/4 (75%)

$9.22 (12.67%)

470

Buy

77

$-3.49 (-4.34%)

68

5 months 3 days ago

10/10 (100%)

$7.05 (10.08%)

480

Buy

76.71

$-3.78 (-4.70%)

74.99

7 months 21 days ago

7/7 (100%)

$11.75 (18.09%)

422

Buy

69.31

$-11.18 (-13.89%)

60

8 months 27 days ago

4/4 (100%)

$7.31 (11.79%)

233

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Simon Hales?

On 2017

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?